Bandingkan Harga & Kinerja Catur Sentosa Adiprana Tbk. (CSAP) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Catur Sentosa Adiprana Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Catur Sentosa Adiprana Tbk. diperdagangkan di Rp284 (kapitalisasi pasar 1,61 T, volume 24 jam 23 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Catur Sentosa Adiprana Tbk. jauh lebih besar — sekitar 9,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (71 rb vs 23 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CSAP | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,61 T | 167,37 M |
Volume | 23 rb | 71 rb |
Lot | 230 | 710 |
Perputaran | 6,57 jt | 17,51 jt |
Harga Rata-rata | 285,67 | 246,63 |
Nilai Transaksi | 6,57 jt | 17,51 jt |
Harga Ekuilibrium Indikatif | 282 | 246 |
Volume Ekuilibrium Indikatif | 3 | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Catur Sentosa Adiprana Tbk.
Catur Sentosa Adiprana Tbk (the company) was established on 31 Dec 1983 based on Notaries Deed No. 93 and the deed of establishment was approved by the the Ministry of Justice dated Sep 18, 1983. Based on the Company’s stockholders’ circular resolution dated June 6, 2007, the stockholders approved the change in the legal status of the Company from a Limited Liability Company “Perseroan Terbatas” with Foreign Capital Investments facility to a Limited Liability Company “Perseroan Terbatas” with Non-Foreign Capital Investments facility/Domestic Capital Investments, including the revocation and/or cancellation of every existing agreement of the Company related to Foreign Capital Investments.
Selengkapnya di halaman CSAP →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
